NEW YORK (GenomeWeb News) – OncoMethylome Sciences today reported fiscal 2008 revenue growth of 15 percent and a 2 percent increase in its net loss year over year.

The Liege, Belgium-based firm brought in total revenues of €3 million ($3.9 million) for 2008, up from revenues of €2.6 million for 2007. OncoMethylome said the increase was due to new products and collbaorations with pharmaceutical companies.

Its net loss for the year was €10.2 million, or €.77 per share, compared to a net loss of €10 million, or €.85 per share, for 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.